The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia

European Journal of Pharmacology

Volumn 299, Issue 1-3, 1996, Pages 103-112

  Bath, Catherine P ^a   Farrell, Louise N ^a   Gilmore, Jeremy ^a   Ward, Mark A ^a   Hicks, Caroline A ^a   O'Neill, Michael J ^a   Bleakman, David ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

(Gerbil); Ca2+ channel, voltage dependent; HEK293 cell; Ischemia; Neuroprotection; NMDA receptor antagonist

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; ELIPRODIL; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OMEGA CONOTOXIN; PROTEIN SUBUNIT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CALCIUM CURRENT; CAROTID ARTERY OBSTRUCTION; CELL LINE; CEREBELLUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC POTENTIAL; GENETIC TRANSFECTION; GERBIL; HIPPOCAMPUS; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NERVE CELL DEGENERATION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PURKINJE CELL; RAT; RECOMBINANT DNA TECHNOLOGY;

ANIMALS; BODY TEMPERATURE; BRAIN ISCHEMIA; CALCIUM CHANNELS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GERBILLINAE; HIPPOCAMPUS; MALE; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PURKINJE CELLS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0029901314     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00846-2     Document Type: Article

References (52)

1. Biton, B.P., P. Granger, A. Carreau, H. Depoortere, B. Scatton and P. Avenet, 1994, The NMDA receptor antagonist eliprodil (SL 82.0715) blocks voltage-operated calcium channels in rat cultured cortical neurons, Eur. J. Pharmacol. 257, 297.
2. Bleakman D., D. Bowman, C.P. Bath, P.F. Brust, E.C. Johnson, C.R. Deal, R.J. Miller, S.B. Ellis, M.M. Harpold, M. Hans and C.J. Grantham, 1995, Characteristics of a human N-type calcium channel expressed in HEK 293 cells, Neuropharmacology 34, 753.
3. Boast, C.A., S.C. Gerhardt, G. Pastor, J. Lehmann, P.E. Ethienne and J. Liebmann, 1988, The N-methyl-D-aspartate antagonist CGS 19755 and CPP reduce ischemic damage in gerbils, Brain Res. 442, 345.
4. Brierley, J.B., 1976, Cerebral hypoxia, in: Greenfield's Neuropathology, eds. W. Blackwood and A. Corsellis (Edward Arnold, London) p. 43.
5. Buchan, A.M. and W.A. Pulsinelli, 1990, Hypothermia, but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia, J. Neurosci. 10, 311.
6. Bullock, R., D.I. Graham, S. Swanson, and J. McCulloch, 1994, Neuroprotective effect of the AMPA receptor antagonist LY 293558 in focal ischemia in the cat, J. Cereb. Blood Flow Metab. 14, 466.
7. Carron, C., A. Jullien and B. Bucher, 1971, Synthesis and pharmacological properties of a series of 2 piperidino alkanol derivatives, Arzneim.-Forsch./Drug Res. 21, 1992.
8. Carter, C., J. Benavides, C. Dana, H. Shoemaker, G. Perrault, D. Danger and B. Scatton, 1991, Non-competitive NMDA receptor antagonists acting on the polyamine site, in: Excitatory Amino Acid Antagonists, ed. B.S. Meldrum (Blackwell Scientific Publications, Oxford) p. 130.
9. Choi, D., 1992, Excitotoxic cell death, J. Neurobiology 23, 1261.
10. Church, J., E.J. Fletcher, K. Baxter and J.F. McDonald, 1994, Blockade by ifenprodil of high voltage activated calcium channels in rat and mouse cultured hippocampal pyramidal neurones; comparison with NMDA receptor antagonist actions, Br. J. Pharmacol. 113, 499.
11. Clissold, D.B., M.J. Pontecorvo, B.E. Jones, M.E., Abreu, E.W. Karbon, R.H. Erickson, K.J. Natilie Jr., S. Borosky, T. Hartman, R.S. Mansbach, R.L. Balster, J.W. Ferkamy and S.J. Enna, 1993, NPC 19377, a potent and selective σ-ligand. II. Behavioural and neuroprotective profile, J. Pharmacol. Exp. Ther. 265, 876.
12. Contreras, P., N. Gray, D. Ragan and T. Lanthorn, 1992, BMY 14802 protects against ischemia-induced neuronal damage in the gerbil, Life Sci. 51, 1143.
13. Corbett, D., S. Evans, C. Thomas, D. Wang and R.A. Jones, 1990, MK-801 reduced cerebral ischemic injury by inducing hypothermia, Brain Res. 514, 300.
14. Crain, B.J., A. Westerkam, A.H. Harrison and J.V. Nadler, 1988, Selective neuronal death after transient forebrain ishaemia in the Mongolian gerbil: a silver impregnation study, Neuroscience 27, 387.
15. Di Fabio, R., C. Pietra, R.J. Thomas and L. Ziviani, 1995, The asymmetric synthesis of both enantiomers of eliprodil, Bioorg. Med. Chem. Lett. 5, 551.
16. Gill, R. and D. Lodge, 1995, The neuroprotective effects of the decahydraisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia, Neuropharmacology 33, 1529.
17. Gill, R., A.C. Foster and G.N. Woodruff, 1987, Systemic administration of MK-801 protects against ischaemia-induced hippocampal neurodegeneration in the gerbil, J. Neurosci. 7, 3343.
18. Gill, R., A.C. Foster and G.N. Woodruff, 1988, MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period, Neuroscience 25, 848.
19. Ginsberg, M.D. and R. Busto, 1989, Rodent models of cerebral ischemia, Stroke 20, 1627.
20. Globus, M.Y.-T., R. Busto, W.D., Dietrich, E. Martinez, I. Valdes and M.D. Ginsberg, 1988, Effect of ischemia on in vivo release of striatal dopamine, glutamate and gamma-aminobutyric acid studied by intracerebral microdialysis, J. Neurochem. 51, 1455.
21. Gotti, B., D. Deverger, J. Bertin, J. Carter, C. Dupont, R. Dupont, J. Frost, B. Gaudillire, E.T. MacKenzie, J. Rousseau, B. Scatton and A. Wick, 1988, Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. 1. Evidence for efficacy in models of focal cerebral ischemia, J. Pharmacol. Exp. Ther. 247, 1211.
22. Gotti, B., J. Benavides, E.T. MacKenzie and B. Scatton, 1990, The pharmacology of focal cortical ischaemia in the mouse, Brain Res. 522, 355.
23. Grotta, J.C., C.M. Picone, P.T. Ostrow, R.A. Strong, R.M. Earls, L.P. Yao, H.M. Rhoades and J.R. Dedman, 1990, CGS 19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia, Ann. Neurol. 27, 612.
24. Hall, E.D., K.E. Pazana and J.M. Braughler, 1988, 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils, Stroke 19, 997.
25. Hamill, A., E. Marty, E. Neher, B. Sakmann and F. Sigworth, 1981, An improved patch clamp technique for high resolution current recordings from cells and cell free membrane patches. Pflüg. Arch. 391, 85.
26. Hayward, N.J., A.T. McKnight and G.N. Woodruff, 1993, Brain temperature and the neuroprotective action of enadoline and dizocilipine in the gerbil model of global-ischemia, Eur. J. Pharmacol. 236, 247.
27. Honda, H. and Y. Sakai, 1987, The mode of action of ifenprodil tartrate in isolated canine cerebral and femoral arteries, Arch. Int. Pharmacodyn. 285, 211.
28. Honda, H., Y. Sakai, T. Iwata, S. Ohba, T. Kanezuka and O. Irino, 1988, Effects of ifenprodil tartrate on α-adrenoceptors and calcium movement in isolated canine saphenous veins, Arch. Int. Pharmacodyn. 292, 112.
29. Ito, U., M. Sportz, J.T. Walker Jr. and I. Klatzo, 1975, Experimental cerebral ischemia in Monglian gerbils: 1. Light microscope observations, Acta Neuropathol. 32, 209.
30. Iversen, L.L., G.N. Woodruff, J.A. Kemp, A.C. Foster, R. Gill and E.H.F. Wong, 1989, Neuroprotective properties of the glutamate antagonist dizoclipine maleate (MK-801) in animal models of focal and global cerebral ischemia, in: Pharmacology of Cerebral Ischemia 1988, ed. J. Krieglstein (CRC Press, Boca Raton, FL) p. 165.
31. Kirino, T., 1982, Delayed neuronal death in the gerbil hippocampus following ischemia, Brain Res. 1, 494.
32. Legendre, P. and G.L. Westbrook, 1991, Ifenprodil blocks NMDA receptors by a two component mechanism, Mol. Pharmacol. 40, 289.
33. McCulloch, J., 1992, Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man, Br. J. Clin. Pharmacol. 34, 106.
34. Mintz, I.H., V.J. Venema, K. Swiderek, T. Lee, B.P. Bean and M.E. Adams, 1992, P-type calcium channels blocked by the spider toxin ω-Aga-IVA, Nature 355, 827.
35. O'Neill, M., M. Canney, B. Earley, J.-L. Junien and B.E. Leonard, 1995a, The novel sigma ligand JO 1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil, Neurochem. Int. (in press).
36. O'Neill, M., M. Caldwell, B. Earley, M. Canney, A. O'Halloran, J. Kelly, B.E. Leonard and J.-L. Junien, 1995b, The σ receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia, Eur. J. Pharmacol. 283, 217.
37. Park, C.K., J. McCulloch, J.K. Kang and C.R. Choi, 1992, Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat, Neurosci. Lett. 147, 41.
38. Poignet, H., J.P. Nowicki and B. Scatton, 1992, Lack of neuroprotective effect of some σ ligands in a model of focal ischemia in the mouse, Brain Res. 596, 320.
39. Pontecorvo, M.J., E.W. Karbon, S. Goode, D.B. Clissold, S.A. Borosky, R.J. Patch and J.W. Ferkany, 1991, Possible cerebroprotective and in vivo NMDA antagonist activities of sigma ligands, Brain Res. Bull. 26, 461.
40. Regan, L.G., 1991, Voltage-dependent calcium currents in Purkinje cells from rat cerebellar vermis, J. Neurosci. 11, 2259.
41. Scatton, B., C. Carter, J. Benavides and C. Giroux, 1991, NMDA receptor antagonists; a novel therapeutic perspective for the treatment of ischaemic brain injury, Cerebrovasc. Dis. 1, 121.
42. Schurr, A. and B.A. Rigor, 1992, The mechanism of cerebral hypoxicischemic damage, Hippocampus 2, 221.
43. Sheardown, M.J., E.O. Nielson, A.J. Hansen, P. Jacobsen and T. Honoré, 1990, 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuro-protectant for cerebral ischemia, Science 247, 571.
44. Sheardown, M.J., P.D. Suzdak and L. Nordholm, 1993, AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischeamia, even when delayed 24 h, Eur. J. Pharmacol. 236, 347.
45. Siesjö, B.K., 1992, Pathophysiology and treatment of focal cerebral ischemia, Part I. Pathophysiology, J. Neurosurg. 77, 169.
46. Smith, M.L. and B.K. Siesjö, 1992, Postischemic treatment with the omega-conopeptide SNX-111 protects the rat brain against ischemic damage, in: Pharmacology of Cerebral Ischemia 1992, ed. J. Krieglstein, p. 161.
47. Smith, S. and B.S. Meldrum, 1992, Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in rat, Stroke 23, 861.
48. Toulmond, S., A. Serrano, J. Benavides and B. Scatton, 1993, Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window, Brain Res. 620, 32.
49. Tsien, R.W., D. Lipscombe, D. Madison, K. Bley and A. Fox, 1995, Reflections on calcium channel diversity, 1988-1994, Trends Neurosci. 52.
50. Williams, M.E., P.F. Brust, D.H. Feldman, S. Patthi, S. Simerson, A. Maroufi, A.F. McCue, G. Velicelebi, S.B. Ellis and M.M. Harpold, 1992, Structure and functional expression of an ω-conotoxin sensitive human N-type calcium channel, Science 257, 389.
51. Young, A.R., M. Bouloy, J.-F. Boussard, L. Edvinsson and E.T. MacKenzie, 1981, Direct vascular effects of agents used in the pharmacotherapy of cerebrovascular disease on isolated cerebral vessels, J. Cereb. Blood Flow Metab. 1, 117.
52. Zhao, Q., M.L. Smith and B.K. Siesjö, 1994, The omega-conopeptide SNX-111, an N-type calcium-channel blocker, dramatically ameriorates brain damage due to transient focal ischemia, Acta Physiol. Scand. 150, 459.